The Fleming Fund

The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.

We support low- and middle-income countries to generate, share and use data to improve antimicrobial use and encourage investment in AMR.

22
Active Country Grants
155
Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
170
National Action Plans developed with Fleming Fund support
11
Active Regional Grants

Stories of change from Malawi, Nepal, Timor-Leste and Kenya, illustrating some of the tangible differences taking place in countries…

The British Embassy Hanoi, in collaboration with FHI 360 launched the second phase of the UK’s Fleming Fund Country Grant (FFCG) – awa…

The UK aid Fleming Fund Country Grant to Indonesia (FFCGI) enters its second phase of support to Indonesia, providing technical assistance…

Phase II of the Fleming Fund in Malawi means a further £3m of investment in laboratories, disease surveillance systems, and the workforc…

Just like our carbon footprint monitors the global environmental impact of harmful greenhouse gases, we also need to track our antibiotic…


Up to £210 million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance and reduce the threa…

Ahead of the September UN General Assembly High-Level Meeting (UNGA-HLM) on antimicrobial resistance (AMR) in New York, we hear from Prof…

There is a growing recognition that both sex (the physical dimension) and gender (the psychosocial dimension) – and the interaction betwe…

With global Sustainable Development Goals (SDGs) threatened by antimicrobial resistance (AMR), how can social science play a critical role…